News
India pharma industry to hit over $38b by 2022
India pharma industry to hit over $38b by 2022
The government is urged to create a research ecosystem that will support the sector's growth.
GIC and investment firm KKR invest $940m in Philippine hospital group
The consortium will subscribe to $136.67m worth of 41.3 million new common shares.
Top five healthcare stocks in Singapore averaged total returns of 29.5% YTD
ISEC leads the pack at 48.6%.
Singapore, Philippines spearhead medtech across SEA
The Lion City’s Diagnostics Development hub has delivered 400 technologies and four products since 2014.
India e-health record market to grow at 5% CAGR to 2025
The implementation of UHC will fuel the shift to digital.
HC Surgical Specialist profits up 38% to $880,000 in Q1
New acquisitions from the previous financial year brought growth.
Japanese pharma sales take hit from 'opaque' pricing system
It will grow at a CAGR of 2.3% to $124b in 2023.
Rentschler strengthens Japanese ties with Summit Pharmaceuticals
The East Asian country is the world’s third largest pharmaceuticals market.
Rentschler strengthens Japanese ties with Summit Pharmaceuticals
The East Asian country is the world’s third largest pharmaceuticals market.
Rentschler strengthens Japanese ties with Summit Pharmaceuticals
The East Asian country is the world’s third largest pharmaceuticals market.
Top Chinese drug distributors grapple with tepid margins
Blame the two-invoice system.
Chinese pharmas face price pressures from Indian entrants under GPO
The entrance of Indian players may cut prices further by 30%.
APAC's employer medical benefit costs may rise 8.7% in 2020
This growth will be led by Malaysia and Thailand.
Singapore lost $1.04b to migraines in 2018
Patients who experienced it for four to 14 days per month lost an average of $14,860.
Temasek advances in bid for stake in $2.5b Metro Pacific hospital unit
This could potentially be the biggest healthcare deal in the Philippines.
IHH Healthcare buys Prince Court Medical Centre for $240m
The deal would give IHH a larger share in the medical tourism market in Klang Valley.
IHH Healthcare profits up 28% to $57.42m in Q2
Singapore and Malaysia’s EBITDA earnings grew 28% and 29%, respectively.
Most Read
1. Asian medical device markets face cost shocks amidst Iran conflict 2. Gene and cell therapy boom drives DNA manufacturing market toward $21.82B by 2034 3. HSA to expand role in accelerating biomedical sector growth: Ong Ye Kung 4. Global dental articulators market to reach $227.8m by 2030 5. AJJ Medtech hits $8m order book with $3m green supply dealResource Center
Read Here
Advertise
Sign Up
Events
Event News
He discusses how healthcare systems in Asia Pacific need to evolve beyond simply expanding coverage and towards delivering equitable, sustainable, and high-impact care.
Commentary
Beyond ChatGPT: The rise of multimodal AI assistants in clinical settings
2026 biotech playbook: Hong Kong at the centre of China’s globalisation